200 Participants Needed

Low Vision Aid System for Age-Related Macular Degeneration

(AMD Trial)

MB
SN
Overseen BySamuel N Markowitz, MD, FRCSC
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Optimal Acuity Corporation
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The purpose of this study is to determine whether the Optimal Acuity Clear-K® Low Vision Aid System provides a safe and effective treatment to improve vision for patients with age-related macular degeneration.

Research Team

MB

Michael Berry, PhD

Principal Investigator

Optimal Acuity Corporation

Eligibility Criteria

This trial is for people over 50 with age-related macular degeneration (AMD) in one or both eyes, confirmed by a retina specialist. Participants must have moderate to severe vision impairment due to AMD but no significant cataracts or corneal diseases. They should not wear contact lenses and must be able to give informed consent.

Inclusion Criteria

I am 50 years old or older.
You do not wear contact lenses.
I am either male or female.
See 21 more

Exclusion Criteria

I have high eye pressure or a history of glaucoma.
Corneal topographic astigmatism greater than 2.00 D (mean value within 3.0 mm optical zone)
Potential Visual Acuity (PVA) in both eyes that is not improved by at least three lines compared to CDVA
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Patients are treated by the Optimal Acuity Clear-K Low Vision Aid System

Immediate

Follow-up

Participants are monitored for safety and effectiveness after treatment

24 months

Treatment Details

Interventions

  • Optimal Acuity Clear-K® Low Vision Aid System
Trial Overview The study tests the Optimal Acuity Clear-K® Low Vision Aid System's effectiveness and safety in improving vision for those with AMD. It aims to see if this treatment can help patients see better.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Treatment armExperimental Treatment1 Intervention
Patients will be treated by the Optimal Acuity Clear-K Low Vision Aid System.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Optimal Acuity Corporation

Lead Sponsor

Trials
4
Recruited
310+

Bochner Eye Institute

Collaborator

Trials
2
Recruited
220+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security